# Aspirin Mouthwash in Treating Patients With Oral Leukoplakia

> **NCT01238185** · PHASE1 · COMPLETED · sponsor: **Institute of Head and Neck Studies and Education, United Kingdom** · enrollment: 40 (estimated)

## Conditions studied

- Precancerous Condition

## Interventions

- **DRUG:** acetylsalicylic acid
- **GENETIC:** gene expression analysis
- **GENETIC:** protein expression analysis
- **OTHER:** laboratory biomarker analysis
- **OTHER:** questionnaire administration
- **PROCEDURE:** biopsy

## Key facts

- **NCT ID:** NCT01238185
- **Lead sponsor:** Institute of Head and Neck Studies and Education, United Kingdom
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2013-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01238185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01238185, "Aspirin Mouthwash in Treating Patients With Oral Leukoplakia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01238185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*